AKOYA BIOSCIENCES INC

AKYA11 Dec 2024
Healthcare
$2.09
+0.03 (+2.55%)
Lowest Today
$2.09
Highest Today
$2.43
Today’s Open
$2.09
Prev. Close
$2.35
52 Week High
$6.31
52 Week Low
$1.88
To Invest in AKOYA BIOSCIENCES INC

AKOYA BIOSCIENCES INC

Healthcare
AKYA11 Dec 2024
+0.03 (+2.55%)
1M
3M
6M
1Y
5Y
Low
$2.09
Day’s Range
High
$2.43
2.09
52 Week Low
$1.88
52-Week Range
52 Week High
$6.31
1.88
1 Day
-
1 Week
+4.91%
1 month return
-27.46%
3 month return
-16.66%
6 month return
+7.79%
1 Year return
-45.72%
3 Years return
-81.2%
5 Years return
-
10 Years return
-
Institutional Holdings
Blue Water Life Science Advisors, LLC
9.48
BlackRock Inc
3.03
Vanguard Group Inc
3
Vanguard Total Stock Mkt Idx Inv
1.78
PARAGON Assoc & PARAGON Assoc II JV
1.59
iShares Russell 2000 ETF
1.42
Geode Capital Management, LLC
1.13

Market Status

Fundamentals
Market Cap
111.02 mln
PB Ratio
7.71
PE Ratio
0
Enterprise Value
154.1 mln
Total Assets
180.37 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. It has a collaboration agreement with NeraCare that enables personalized therapy selection for early-stage melanoma patients. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.
Organisation
AKOYA BIOSCIENCES INC
Employees
330
Industry
Medical Instruments & Supplies
CEO
Mr. Brian  McKelligon
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step

Click here to see your activities